期刊文献+

慢性阻塞性肺病患者血清脑钠肽水平变化及临床意义研究 被引量:10

Prognostic value and clinical significance of plasma brain natriuretic peptide levels in patients with COPD
下载PDF
导出
摘要 目的探讨慢性阻塞性肺病患者血清脑钠肽水平的预测价值及临床意义。方法测定86例慢性阻塞性肺病血清脑钠肽(BNP)0~24 h,24~48 h和恢复期的水平,并与40例健康体检者(对照组)进行比较,分析慢性阻塞性肺病患者急性加重和恢复期的BNP水平。结果与对照组相比较,在0~24 h,24~48 h和恢复期时间段慢性阻塞性肺病患者血清BNP水平均显著升高(P<0.001);0~24 h,24~48 h血清BNP水平明显高于缓解期(P<0.001)。结论动态监测BNP的变化对慢性阻塞性肺病患者有较好的预测作用。 Objective To explore the prognostic value and clinical significance of brain natriuretic peptide(BNP) level in patients with chronic obstructive pulmonary diseases(COPD).Methods Eighty-six patients(45 mechanical ventilation group and 41 noninvasive mechanical ventilation group)with COPD from June 2009 to March 2011 were studied and 40 volunteer with healthy examined people as controls participated in this study.Plasma BNP concentrations were measured on 0~24 h,24~48 h and paracmasia.Results There was a statistical difference in plasma BNP concentrations both in group mechanical ventilation and noninvasive mechanical ventilation among 0~24 h,24~48 h and paracmasia(P0.001),0~24 h and 24~48 h plasma BNP levels differed significantly in patients who presented with acute exacerbations compared with control group(P0.001).Conclusion Serial determination of plasma BNP concentration has a better prognostic value for patients with COPD.
出处 《安徽医药》 CAS 2012年第1期65-67,共3页 Anhui Medical and Pharmaceutical Journal
关键词 脑钠肽 慢性阻塞性肺病 brain natriuretie peptide chronic obstructive pulmonary disease
  • 相关文献

参考文献10

  • 1Suzuki M, Hamada M, Yamamoto K, et al. Brain natriuretic peptide as a risk marker for incident hypertensive cardiovascular events[ J]. Hypertens Res, 2002,25 ( 5 ) :669 - 73.
  • 2Mueller C, Breidthardt T, Laule-Kilian K, et al. The integration ofBNP and NT-proBNP into clinical medicine[ J]. Swiss Med Wkly, 2007,137(1/2) :4 - 12.
  • 3赵亮,罗以勤,孔建新,濮跃晨,马筱玲.急性心肌梗死患者血浆BNP、D-二聚体、纤维蛋白原水平变化与临床观察分析[J].安徽医药,2009,13(3):283-284. 被引量:13
  • 4Nagaya N, Nishildmi T, UematBu M, et al. Plasma brain natriuretic peptidc as a prognostic indicator in patients with primary pulmonary hypertension[ J]. Circulation ,2000,102 ( 8 ) :865 - 70.
  • 5Leuchte HH, Holzapfel M, Baumgartner RA, et al. Clinical signifi- cance of brain natriuretie peptide in primary pulmonary hypertension [J]. J Am Coil Cardiol,2004,43(3) :764 -70.
  • 6Cetin I, Tokel K, Varan B, et al. Evaluation of right ventricular func- tions and B - type natriuretie peptide levels by eardiopulmonary ex- ercise test in patients with pulmonary regurgitation after repair of tet- ralogy of Fallot[ J]. J Card Surg,2008,23(5) :493 -8.
  • 7Ma KK, Ogawa T, De Bold AJ. Selective upregulation of cardiac brain natriuretic peptide at the transcriptional and translational lev- els by pro - inflammatory cytokines and by conditioned medium de- rived from mixed lymphocyte reactions via p38 MAP kinase [ J]. J Mol Cell Cardiol,2004,36(4) :505 - 13.
  • 8Stolz D, Breidthardt T, Christ-Crain M, et al. Use of B-type natriuret- ie peptide in the risk stratification of acute exacerbations of COPD [ J ]. Chest,2008,133 ( 5 ) : 1088 - 94.
  • 9贾维.慢性阻塞性肺疾病患者脑钠肽水平改变的意义[J].中国基层医药,2011,18(10):1390-1391. 被引量:12
  • 10陈泓,蔡敏,苏士成.B型脑钠肽对COPD急性加重期的预后价值[J].山东医药,2010,50(40):77-79. 被引量:23

二级参考文献16

  • 1肖羚,李向斌,张熠,宁忠平,张翼.青年人急性心肌梗死的临床和冠状动脉造影特点分析[J].中国动脉硬化杂志,2006,14(8):709-711. 被引量:13
  • 2Arakawa N, Nakamura M, Aoki H, et al. Relationship between plasma level of brain natruretic peptide and myocardial infarct size[ J]. Cardiology,1994,85 (5) :334 -40.
  • 3Nicholls MG. The natriuretic peptides in heart failure [ J ]. Intern Med,1994,235(6) :515 -26.
  • 4Tapanainen JM, Lindga-en KS, Makikallio TH, et al. Natriuretic peptides as predictors of non-sudden and sudden cardiac death after acute myocardial infarction in the beta-blocking era [ J ]. Am Coll Cardio1,2004,43 (5) :757 - 63.
  • 5Stolz D,Breidthardt T,Christ-Crain M,et al.Use of B-type natriuretic peptide in the risk stratification of acute exacerbations of COPD[J].Chest,2008,133(5):1088-1094.
  • 6Maisel A,Mueller C,Adams K Jr,et al.State of the art:Using natriuretic peptide levels in clinical practice[J].Eur J Heart Fail,2008,10(9):824-839.
  • 7Nagaya N,Nishikimi T,Uematsu M,et al.Plasma brain natriuretic peptide as a prognostic indicator in patients with primary pulmonary hypertension[J].Circulation,2000,102(8):865-870.
  • 8Park MH,Scott RL,Uber PA,et al.Usefulness of B-type natriuretic peptide as a predictor of treatment outcome in pulmonary arterial hypertension[J].Congest Heart Fail,2004,10(5):221-225.
  • 9Silver MA.The natriuretic peptide system:kidney and cardiovascular effects[J].Curr Opin Nephrol Hypertens,2006,15(1):14-21.
  • 10Gooneratne NS,Patel NP,Corcoran A,et al.Chronic obstructive pulmonary disease diagnosis and management in older adults.J Am Geriatr Soc,2010,58(6):1153-1162.

共引文献42

同被引文献122

  • 1林文辉,王齐增,周仁芳,马湘俊,林斌,王迤凡.血浆B型钠尿肽对高血压病左心室重构的影响[J].中国老年学杂志,2005,25(11):1328-1329. 被引量:5
  • 2蒋作锋,韦建瑞,余慧文,郭顺华,张锐,张文超,陈辉,黄丽萍,郭衡山.原发性高血压患者N端脑钠肽前体测定及其意义[J].岭南心血管病杂志,2005,11(6):383-385. 被引量:4
  • 3李冬,焦连亭.脑钠素与肾损伤[J].国际检验医学杂志,2006,27(12):1094-1096. 被引量:10
  • 4马艳良,何权瀛.步行试验对慢性阻塞性肺疾病患者的意义[J].中华结核和呼吸杂志,2007,30(9):699-701. 被引量:14
  • 5Mair J, Hammerer-lecher A, Puschendorf B. The impact of cardiac natriuretie peptide determination on the diagnosis and management of heart failure[J]. Clin Chem Lab Med, 2001,39(7) :571-588.
  • 6de Lemos JA, McGuire DK, Drazner MH. B type natriuretie peptide in cardiovascular disease[J]. Lancet, 2003, 362(3) :316-322.
  • 7Maeda K,Tsutamoto T,Wada A,et al. Plasma brain natriuretic peptide as a biochemical marker of high left ventricular end-diastolic pressure in patients with symptomatic left ventrieular dysfunction[J]. Am Heart J,1988, 135(5) :825-832.
  • 8Redfield MM, Rodeheffer RJ, Jacobsen SJ;et al. Plasma brain natriuretic peptide concentration:impact of age and gender[J]. J Am Coil Cardiol, 2002,40 (10) : 976-982.
  • 9Lavila G, Bisi G, Lazzeri C, et al. Cardiovascular effects of brain natriuretic peptide in essential hypertension[J]. Hypertension, 1995,25 (14) : 1053-1056.
  • 10Henkel DM, Glockner J, Miller WL. Association of myo cardial fibrosis: B-Type natriuretie peptide and cardiac magnetic resonance parameters of remodeling in chronic isehemic cardiomyopath[J]. Am J Cardiol, 2012,109(3) : 390-394.

引证文献10

二级引证文献77

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部